NASDAQ:RNAZ
TransCode Therapeutics
- Stock
Last Close
0.88
17/05 20:00
Market Cap
476.80K
Beta: -
Volume Today
3.90M
Avg: 1.67M
PE Ratio
−0.06
PFCF: −0.23
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
net income | -607.21K - | -2.34M 286.01% | -6.84M 191.97% | -17.56M 156.67% | -18.55B 105,485.70% | |
depreciation and amortization | 42.47K - | 98.61K 132.18% | 516.75M 523,951.27% | |||
deferred income tax | 876.19K - | 890.95K 1.68% | ||||
stock based compensation | 1.40K - | 45.44K 3,152.97% | 186.00K 309.29% | 395.33K 112.55% | 1.04B 262,185.08% | |
change in working capital | -4.70K - | 309.76K 6,685.10% | 432.39K 39.59% | 1.31M 202.63% | -1.30B 99,145.56% | |
accounts receivables | -360.23K - | |||||
inventory | 360.23K - | |||||
accounts payables | -54.74K - | 191.25K 449.38% | 2.29M 1,094.78% | 1.84M 19.31% | -1.30B 70,394.33% | |
other working capital | 50.04K - | 118.51K 136.84% | -1.85M 1,663.31% | -535.20K 71.11% | 1.30B 242,257.99% | |
other non cash items | 102.01K - | 1.50M 1,366.23% | 39.47K 97.36% | -890.95K 2,357.23% | -1.08B 121,351.55% | |
net cash provided by operating activities | -508.51K - | -492.97K 3.06% | -5.27M 968.40% | -15.76M 199.28% | -18.07B 114,567.86% | |
investments in property plant and equipment | -254.82K - | -100.92K 60.40% | ||||
acquisitions net | 3K - | |||||
purchases of investments | ||||||
sales maturities of investments | ||||||
other investing activites | -35.61M - | |||||
net cash used for investing activites | -251.82K - | -100.92K 59.92% | -35.61M 35,184.73% | |||
debt repayment | -500K - | -1.12M 123.30% | ||||
common stock issued | 26.34M - | 5.99M 77.26% | 15.91B 265,542.41% | |||
common stock repurchased | ||||||
dividends paid | ||||||
other financing activites | 1M - | 2.23M 123.30% | -818.55K 136.66% | -5.98M 630.93% | ||
net cash used provided by financing activities | 500K - | 1.12M 123.30% | 25.52M 2,185.37% | 5.99K 99.98% | 15.91B 265,642,311.09% | |
effect of forex changes on cash | ||||||
net change in cash | -8.51K - | 623.54K 7,428.93% | 20.00M 3,107.12% | -15.86M 179.30% | -2.20B 13,778.78% | |
cash at beginning of period | 212.98K - | 204.47K 3.99% | 828.02K 304.96% | 20.83M 2,415.15% | 4.97B 23,756.96% | |
cash at end of period | 204.47K - | 828.02K 304.96% | 20.83M 2,415.15% | 4.97M 76.14% | 2.77B 55,603.81% | |
operating cash flow | -508.51K - | -492.97K 3.06% | -5.27M 968.40% | -15.76M 199.28% | -18.07B 114,567.86% | |
capital expenditure | -254.82K - | -100.92K 60.40% | ||||
free cash flow | -508.51K - | -492.97K 3.06% | -5.52M 1,020.09% | -15.86M 187.29% | -18.07B 113,838.37% |
All numbers in USD (except ratios and percentages)